Interleukin-6 (IL-6) and C-reactive protein (CRP, a surrogate marker for IL-6) are important in monoclonal gammopathy of undetermined significance (MGUS) and myeloma. Smoking and obesity may elevate CRP levels, while statins decrease CRP levels. A case-control study in 200 MGUS patients found that statin use, smoking history and obesity do not affect MGUS progression.
|Original language||English (US)|
|Number of pages||3|
|State||Published - May 1 2004|
- Hydroxymethylglutaryl-CoA reductose inhibitors
ASJC Scopus subject areas